Загрузка...
Towards a commercial process for the manufacture of genetically modified T cells for therapy
The recent successes of adoptive T-cell immunotherapy for the treatment of hematologic malignancies have highlighted the need for manufacturing processes that are robust and scalable for product commercialization. Here we review some of the more outstanding issues surrounding commercial scale manufa...
Сохранить в:
| Опубликовано в: : | Cancer Gene Ther |
|---|---|
| Главные авторы: | , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4356749/ https://ncbi.nlm.nih.gov/pubmed/25613483 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2014.78 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|